284
additionally analogous 5,6- and 7,8-dihydrodiol products were
[22]. Above biphenyl dioxygenase produced 2ꢀ,3ꢀ-dihydroepoxy
compounds from flavanone and cis-/trans-isoflavan-7-ols [23,24].
Another interesting biotransformation, occurred in the case of
flavone and its derivatives, was C2-C3 double bond reduction
leading to flavanone moiety [25]. Seo et al. reported also regio-
and stereo-specific hydroxylation of flavanone and isoflavanone
using sitedirected mutants of naphtalene dioxygenase which was
The big advantages of dihydrochalcones as potential food addi-
tives are their safety and stability. Nakamura et al. [5] reported that
dihydrochalcones exhibited higher antioxidant activities than the
corresponding flavanones. Lin et al. [27] characterized phloretin,
dihydrochalcone of naringenin, and 12 other compounds isolated
from apples for their hydroxyl radical scavenging activity and cel-
lular tyrosinase inhibitory activity, suggesting their possible use as
cosmetic agents. Phloretin was suggested to induce apoptosis in
HL60 cells through the inhibition of protein kinase C activity [28].
Dihydrochalcones have also received considerable attention as food
sweeteners, for instance neohesperidin dihydrochalcone, which is
more than 300 times sweeter than sugar.
Chemical methods of hydrogenation with molecular hydrogen
involve the use of catalysts, such as metal complexes and other
compounds harmful to the environment. Selective hydrogenation
tion due to its wide application in synthesis of many fine chemicals
palladium, iridium, and other metal complexes were used for
these transformations [29,30]. Chemoselective hydrogenation of
an olefinic fragment linked to an aromatic ring in ␣,-unsaturated
ketones has also been noted [31–33]. Kim et al. [34] reported about
the method of reduction of flavone to dihydrochalcone using an
excess of ammonium formate in the presence of Pd-C.
2.1.2. Xanthohumol (4)
Xanthohumol (4) was isolated from supercritical carbon diox-
ide extracted hops obtained from Production of Hop Extracts of
Fertilizer Institute, Puławy, Poland. The method of isolation and
purification was reported by Anioł et al. [36]. The product was
obtained as yellow-orange crystals, mp. 170–172 ◦C. The spectro-
scopic data were in accordance with those previously reported [37].
2.2. General methods
The course of biotransformations was controlled by means of
TLC and HPLC.
Thin layer chromatography was carried out using Kiesgel 60 F254
silica gel (0.2 mm, Merck) with various solvent systems as eluents.
Compounds were visualized by spraying the plates with a solution
of 10 g of Ce(SO4)2 and 20 g of phosphomolybdic acid in 1 L of 10%
H2SO4 and heating.
Composition of reaction mixtures was established by high-
performance liquid chromatography (HPLC), performed on
a
Waters 2690 instrument fitted with 2690 separations module and
996 photodiode array detector and Millennium 32 software. A
reverse phase C-18 column (Marcherey Nagel, NUCLEODUR 100-
5 C18 ec, 4.6 mm × 250 mm) was used. The mobile phase consisted
of two solvents: A – 1% HCOOH in MeCN, B – 1% HCOOH in H2O. A
gradient elution from 40% solvent A to 60% solvent B over 28 min
was used at the flow rate of 1 mL/min.
Products were separated by column chromatography using sil-
ica gel Kieselgel 60 (230–240 mesh, Merck) and hexane/acetone
or hexane/dichloromethane/diethyl ether mixtures. Melting points
were recorded on a Boetius apparatus.
Structures of isolated products were confirmed by spectroscopic
methods. 1H NMR and 13C NMR spectra were recorded on NMR
Bruker Avance II DRX 300 and Bruker Avance II DRX 600 MHz
spectrometers with the tetramethylsilane (TMS) as an internal ref-
erence. The NMR spectra were measured in CDCl3 or acetone-d6. To
confirm the presence of characteristic absorption bands, IR spectra
were measured using a FT-IR Thermo-Nicolet IR 300 spectrometer.
HRESI-MS spectra were taken on a Bruker micrOTOF-Q spectrom-
eter. The structures of the known compounds were confirmed by
comparison of their spectroscopic properties with data published
in the literature.
Due to the potential ability of bacterial cells to promote bio-
transformation reactions, we decided to study biotransformation
of chalcone (1), 4-methoxychalcone (2), chalconaringenin (3), xan-
thohumol (4), flavanone (5) and naringenin (6). In this report, the
whole cells of Rhodococcus sp. DSM 364 and Gordonia sp. DSM
44456 were used to obtain hydrogenation products of flavonoid
compounds.
2.3. Microorganisms
2. Experimental
Microorganisms (Rhodococcus, Gordonia, Micrococcus, Strepto-
myces, Bacillus, Pseudomonas, Dietzia) were purchased from the
Polish Collection of Microorganisms (PCM) of the Institute of
Immunology and Experimental Therapy Polish Academy of Sci-
ences in Wroclaw and from German Microorganisms Culture
Collection (DSMZ).
Biomass was determined by the dry weight method. Samples
(10 mL) were filtered on Milipore HA filters, the residue was washed
with distilled water (2 × 5 mL) and dried at 105 ◦C to a constant
weight using the MAX 50/1/NH apparatus, RADWAG.
2.1. Chemicals
All used chemicals were commercially available. Substrates
for biotransformation were purchased from Sigma–Aldrich or
obtained according to procedures described below.
2.1.1. Chalconaringenin (3)
Chalconaringenin (3) was prepared according to the general
procedure described previously [35], which was modified. Thus,
naringenin (1 g, 3.67 mmol) was dissolved in methanol (10 mL) and
added to 200 mL of 20% KOH. The reaction mixture was stirred
at 40 ◦C for 4 h, acidified with 2 M HCl to pH = 6 and extracted
with diethyl ether (3 × 100 mL). The organic layer was separated,
washed with water (3 × 100 mL). The combined organic extracts
were dried over Na2SO4, filtered and concentrated in vacuo. The
crude residue was purified by column chromatography on silica
gel (chloroform/methanol 5/0.5, v/v) to afford 0.80 g (80%) of yel-
low crystals, mp. 256–258 ◦C. IR, 1H NMR, 13C NMR spectra and HR
ESI-MS are given in supplementary data.
2.4. Screening procedure
25 mL of the medium in a 100 mL Erlenmeyer flask containing
1 g of glucose, 2.5 g of malt extract, and 1 g of yeast extract (pH 7.2)
were inoculated with a suspension of a microorganism and then
incubated for 48 h at 28 ◦C on a rotary shaker at 200 rpm. After that,
1 mg of a substrate dissolved in 1 mL of acetone was added. Every
24 h, portions of 5 mL of the transformation mixture were taken
out and extracted with 10 mL of ethyl acetate and centrifuged at
4 ◦C for 10 min at 15,000 rpm. The extracts were dried over Na2SO4,
concentrated in vacuum and analyzed by HPLC and TLC.